OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at Ikena Oncology, Inc. (IKNA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 4, 2023, OrbiMed Genesis GP LLC's relationship to Ikena Oncology, Inc. (IKNA) is Director, and currently has 2,251,218 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IKNA insiders.
Data Source: SEC.
OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at IKNA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 5, 2023 | Acquisition -- (Common Stock) | 153121 | 0 | 2251218 |